International Conference on Microbial Drug Discovery and Therapeutics
(ICMDDT-26)

19th December 2026 || Coimbatore - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Microbial Drug Discovery and Therapeutics (ICMDDT), scheduled to be held on 19th December 2026 in Coimbatore, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Microbiology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Innovations in Antimicrobial Drug Discovery
    This track focuses on the latest advancements in the discovery of antimicrobial agents. It will explore novel compounds, mechanisms of action, and the potential for overcoming resistance. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Molecular Diagnostics in Microbial Pathogenesis
    This session will delve into cutting-edge molecular diagnostic techniques for identifying microbial pathogens. Emphasis will be placed on their application in clinical settings and their role in improving patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 03 – Translational Research in Microbial Therapeutics
    This track aims to bridge the gap between laboratory research and clinical application of microbial therapeutics. Discussions will include successful case studies and challenges faced in translational research. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Clinical Research on Antimicrobial Resistance
    This session will address the growing challenge of antimicrobial resistance in clinical settings. Researchers will present findings on resistance mechanisms and strategies for effective management. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Laboratory Techniques in Microbial Drug Development
    This track will highlight innovative laboratory techniques used in the development of microbial drugs. Participants will discuss methodologies that enhance the efficiency and effectiveness of drug discovery. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Pathogen-Host Interactions: Implications for Therapy
    This session will explore the complex interactions between pathogens and their hosts. Understanding these dynamics is crucial for developing targeted therapeutic strategies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 07 – Therapeutic Innovations in Microbial Infections
    This track will showcase novel therapeutic approaches for treating microbial infections. Emphasis will be placed on innovative strategies that address current limitations in treatment. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 08 – Biotechnology Applications in Microbial Drug Discovery
    This session will focus on the role of biotechnology in enhancing microbial drug discovery processes. Participants will discuss biotechnological advancements that facilitate the identification and development of new therapeutics. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 09 – Emerging Trends in Microbial Therapeutics
    This track will examine emerging trends and future directions in microbial therapeutics. Discussions will include the impact of new technologies and research findings on therapeutic development. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Regulatory Challenges in Microbial Drug Development
    This session will address the regulatory landscape surrounding microbial drug development. Experts will discuss the challenges and opportunities in navigating regulatory pathways for new therapeutics. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 11 – Global Perspectives on Microbial Drug Resistance
    This track will provide a global overview of microbial drug resistance and its implications for public health. Participants will share insights on international efforts to combat resistance and promote effective therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228